Trimetazidine: Activating AMPK Signal to Ameliorate Coronary Microcirculation Dysfunction after Myocardial Infarction
Background: Myocardial ischemia-reperfusion (I/R) injury and coronary microcirculation dysfunction (CMD) are observed in patients with myocardial infarction after vascular recanalization. The antianginal drug trimetazidine has been demonstrated to exert a protective effect in myoc...
Saved in:
Main Authors: | Xiaolong Qu, Pan Yang, Li Jiao, Yuehui Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2025-01-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/30/1/10.31083/FBL25565 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myocardial Bridging, Unusual Cause of Myocardial Infarction; Case Report and Review of Literature
by: Merga Daba, et al.
Published: (2025-01-01) -
Recurrent Spontaneous Coronary Artery Dissection as the Cause of Repeated Myocardial Infarctions
by: Arnon Møldrup Knudsen, et al.
Published: (2025-01-01) -
Treatment selection factors and outcome comparison in acute myocardial infarction
by: Elham Gholamian, et al.
Published: (2024-11-01) -
Anatomy-Informed Multimodal Learning for Myocardial Infarction Prediction
by: Ivan-Daniel Sievering, et al.
Published: (2024-01-01) -
Acute myocardial infarction with large coronary aneurysmal dilatation and thrombosis: A case report
by: Zhongwei Li, et al.
Published: (2025-02-01)